Acid Exfoliation Technology — Material Selection Guide

Key Technical Parameters #

Picking the right acid exfoliant isn’t just a chemistry decision — it’s a sourcing decision, a regulatory decision, and a consumer-experience decision, all at once. Brand partners come to us with a finished-product concept, and the first thing we do is work backwards: what does the acid raw material need to deliver, and which grade actually delivers it? This guide walks through the six criteria we apply in our material intake process, the numeric thresholds that matter for production, and what you should actually write into your purchase order to avoid receiving the wrong thing. The brands that get this right early avoid costly reformulation cycles at the 500 kg scale.

Six Criteria That Determine Whether a Raw Material Makes It Into a Formula #

We use an internal intake checklist we call the ACE-RQ6 screen — six pass/fail criteria applied to every acid raw material before it moves from sample receipt to formulation trial. Not every supplier understands why we ask for all of it. Here’s the reasoning behind each.

1. Free acid content and purity grade

This is the one most brands underspecify in their PO. Glycolic acid, for example, is commercially available in grades ranging from 70% aqueous solution up to 99%+ anhydrous crystal. The 70% solution is easier to handle but introduces water load into your formula — which shifts your preservative calculation and your pH adjustment volume. We target a minimum 99.0% purity for crystalline AHAs when the formula runs at concentrations above 8%, because below that threshold, batch-to-batch variance in the acid load becomes visible in pH drift during stability. Lactic acid is murkier: most cosmetic grades are 85–90% aqueous, and the L-isomer content matters. We specify ≥ 99.5% L-lactic acid (not racemic DL-lactic) because the D-isomer doesn’t exfoliate — it just adds to acid load without efficacy contribution.

2. pH of 1% aqueous solution

Every acid raw material we receive goes through a 1% aqueous solution pH check before anything else. This gives us a fast signal on lot-to-lot consistency. For glycolic acid, we expect a 1% solution to land at pH 2.4–2.7. If it reads above 2.9, the lot has been partially neutralised somewhere in the supply chain — often from improper storage or container contamination. That lot fails incoming QC, full stop. For salicylic acid, the 1% solution target is pH 2.8–3.1. Deviation above pH 3.4 in a salicylic acid lot has, in our experience, correlated with reduced comedolytic performance in the finished product — though we’re still building the dataset to call that a statistically solid claim.

3. Heavy metals and impurities profile

The EU Cosmetics Regulation 1223/2009 sets limits for specific heavy metals in finished products, and working backwards, that means your raw acid material needs a clean CoA for lead (≤ 10 ppm in finished product under Annex III limits), arsenic, and cadmium. We’ve seen glycolic acid lots — particularly from certain secondary market suppliers — come in with lead readings of 15–22 ppm in the raw material. That’s not usable at typical AHA use levels without dilution well below functional range. We cross-check every CoA against our own ICP-MS screen on the first lot from any new supplier. The second lot gets a visual CoA review unless something triggers a retest flag.

4. Particle size distribution (for solid/powder grades)

Mandelic acid and citric acid both arrive as crystalline powders, and particle size matters more than most people expect. Coarse crystals above 500 µm dissolve slowly at the mixing temperatures we use for sensitive-skin emulsions — we don’t go above 50°C for those bases. Incomplete dissolution leaves undissolved particulates that show up as grit in the finished texture, which is a sensory failure, not just a stability one. Our spec asks for D90 ≤ 200 µm on powdered acid grades. Suppliers rarely volunteer this data. You have to ask for it explicitly, and you should write it into your PO.

5. Microbial load of the raw material

Organic acids are broadly antimicrobial in finished-product context, but the raw material itself — especially aqueous lactic acid solutions — can carry microbial contamination from the fermentation process. We run a plate count on every incoming lactic acid lot: our internal limit is ≤ 100 CFU/g. One lot we received in Q3 2023 came in at 840 CFU/g — not unsafe for a finished product given the acid environment, but it triggered our Category B review under the QC-07 material risk procedure and we held the lot pending retesting. The finished formula passed challenge testing, but we flagged the supplier.

6. Optical purity / chirality (L-form vs racemic)

This one is mostly relevant to lactic and mandelic acid. The market has moved toward specifying L-mandelic acid over racemic mandelic specifically because of the skin tolerance argument — some dermatologists have positioned it that way, and clean-beauty brand briefs follow. Whether the chirality difference is clinically meaningful at 4–8% use levels, we’re honestly not fully convinced. The evidence is suggestive but thin. Our current position: if a brand is building a professional-grade peel line, specify L-form; for a retail leave-on product at 4–5%, racemic mandelic is functionally equivalent and costs roughly 30–40% less per kg.

Material Decision Matrix #

The table below summarises how the six criteria apply differently across the four most common acid actives we formulate with. Blank cells indicate the criterion doesn’t typically apply to that material.

The glycolic acid row is the one that catches brands off guard most often. Because glycolic is the most commoditised acid in this category, there’s a wide range of supplier quality in the market, and the delta between a 99.5% pharma-grade lot and a 96% technical-grade lot is not visible on a CoA summary — you have to look at the full impurity profile.

For salicylic acid, the pharmacopoeia-grade spec matters because we formulate to FDA Cosmetics Guidelines for US-bound SKUs and salicylic acid sits under OTC monograph rules in that market. Using a non-pharmacopoeia grade in an OTC product is a compliance gap. Our acid-exfoliation-technology formulation library carries batch records specifically for OTC-compliant salicylic systems.

What Actually Goes Wrong at Scale — Three Material Failures We’ve Seen #

Glycolic acid lot substitution mid-production run

This is the most common scale-up failure in this category. A brand approves a formula at lab scale, stability looks good, everything signs off. Then the production batch uses a different lot of glycolic acid — different supplier, technically within spec on the CoA — and the batch comes off the line 0.3–0.4 pH units higher than target. At 10% glycolic in a leave-on serum, that pH shift is not cosmetic. It changes the free acid fraction meaningfully and it moves you outside the stability-validated range. We’ve seen this result in a failed 4-week accelerated stability check (40°C/75% RH) when the original lab formula passed 12 weeks without issue. The root cause was a glycolic acid lot with higher buffering capacity from residual sodium glycolate impurities — nothing the standard CoA would catch.

Our response was to add a buffering capacity titration to our ACE-RQ6 screen: we titrate a 10% solution with 0.1N NaOH to pH 4.0 and measure the volume required. More than 2.8 mL/g signals buffering anomaly. That’s an internal method, not an industry standard — but it’s caught two problematic lots since we implemented it.

Lactic acid fermentation byproducts

Some lactic acid grades — particularly the lower-cost fermentation-derived grades — carry residual pyruvate, acetate, and succinic acid at levels that are fine in isolation but interact poorly with certain fragrance components. We had one project where a rice-milk lactic acid product developed a sour off-note at 4 weeks accelerated storage. The lactic acid CoA was fine. The fragrance CoA was fine. Combined, the pyruvate residuals in the lactic acid were reacting with an ester component in the fragrance — we tracked it down by running the formula with and without fragrance, and the off-note appeared exclusively in the fragranced version. The solution was switching to a higher-purity synthetic lactic acid grade at a cost premium of about $4–6/kg. Not a dramatic cost at finished-product scale, but it added three weeks to the qualification timeline because we had to rerun stability from the start.

Salicylic acid solubility in cold-process formulas

Short answer: don’t attempt to dissolve salicylic acid in an aqueous continuous phase below 40°C. It doesn’t fully dissolve, and the undissolved crystals don’t always show up immediately — they appear at week 3–4 as a visible haze or precipitate, sometimes mistaken for microbial contamination. Cold-process formulation is popular for the “preservative-free” and minimal-heat narrative, but salicylic acid is not compatible with that workflow. We almost always push back on briefs that combine salicylic acid with cold-process aesthetics. When a brand really needs that positioning, we use a pre-dispersed 10% salicylic acid propylene glycol solution and add it last, with mixing temperature held at minimum 45°C before cool-down.

Does Biofermented vs Synthetic Origin Change Anything Formulatorically? #

For most brands: barely.

The functional chemistry is identical — L-lactic acid is L-lactic acid, whether it comes from corn fermentation or chemical synthesis. The difference shows up in impurity profiles and, occasionally, in the clean-beauty claim. Biofermented lactic acid from certified non-GMO corn fermentation carries a slightly different residual profile (trace pyruvate, as mentioned above) compared to synthetic grades, and some sensitive-skin formulas with complex fragrance systems have performed better on synthetic grades in our stability work. That’s not a universal finding — it’s based on the projects we’ve run, and the formula context matters enormously.

Where origin does matter is regulatory claims. For brands targeting the “naturally derived” or “bio-based” positioning, fermentation origin is relevant for label claims in some markets. China NMPA, under NMPA Cosmetic Regulation guidelines, does not differentiate between synthetic and fermentation-derived acids for registration purposes — so the claim value is marketing, not regulatory, in that market.

Our barrier-repair and sensitive-skin formulation work often involves lactic acid at 2–5%, where we typically recommend biofermented L-lactic specifically for the positioning value, with a tighter incoming CoA spec to manage the pyruvate issue.

There is one area where we’re genuinely uncertain: the clinical differentiation between biofermented and synthetic mandelic acid. One split-face RCT (n=44, 10 weeks) published in 2022 showed a 22% reduction in post-inflammatory hyperpigmentation using L-mandelic acid at 10%, but the study used a pharmaceutical-grade synthetic L-form — so you can’t directly extrapolate that to fermentation-derived racemic mandelic at 5–8%. We reference this study in brand briefs, but we’re always careful to flag the grade mismatch. The data is useful; the applicability has limits.

Formulation Notes for Brand Partners #

When you brief us on an acid exfoliant product, the first questions we ask aren’t about the acid — they’re about market, format, and the on-pack concentration claim you want to make.

Market determines your concentration ceiling and your regulatory classification. A 10% glycolic leave-on in the EU sits under the EU Cosmetics Regulation 1223/2009 with mandatory on-pack warnings above 3% AHA (Annex III). The same formula in the US is unregulated cosmetic territory. China NMPA requires separate registration and has a 6% AHA ceiling for leave-on products without special category filing. The material you source needs to match the regulatory tier you’re operating in.

The most common mistake we see in briefs is specifying the acid without specifying the grade. “5% lactic acid serum” tells us almost nothing — we still need to know: aqueous or anhydrous basis? L-form only? Biofermented? What’s the acceptable lead range? Brands often assume this is our problem to solve, and technically it is, but it becomes your problem if the launched product can’t be reordered because we can’t source the same material lot-to-lot without a written spec.

Realistic timelines: lab samples in 2–3 weeks from approved material spec, accelerated stability (4–8 weeks at 40°C/75% RH) run concurrently with initial sample review, 24-month real-time stability initiated at the same time. Stability is the long pole. Plan for it.

Frequently Asked Questions #

We want to use 10% glycolic acid — can we use the industrial-grade material to save cost?

We’d steer you away from it for a leave-on product. Industrial-grade glycolic acid typically has a broader impurity spec and can carry heavy metals above the thresholds that matter at finished-product level — particularly if your formula concentration runs high. For a rinse-off format at lower concentration, the calculus changes, but we’d still want an ICP-MS screen on the first lot before committing to that supply chain.

Is salicylic acid still usable in EU-marketed products after recent regulatory reviews?

Yes, with specific conditions. Under EU Cosmetics Regulation 1223/2009, salicylic acid is permitted at up to 2% in rinse-off cosmetics and 0.5% in leave-on products (with “not for use on children under 3 years” warning). The SCCS Scientific Opinion from 2022 maintained those limits. What brands sometimes miss is that “salicylic acid” as a fragrance component is separately regulated — if your fragrance blend contains salicylate esters, they count toward the limit in some interpretations. Worth checking at brief stage.

What’s a realistic stability failure timeline for a misspecified acid raw material?

In our experience, pH-related failures from a misspecified acid lot usually surface by week 4–6 of accelerated stability (40°C/75% RH). Textural failures from undissolved particles appear earlier — sometimes within 2 weeks. The problem with both is that they can look fine at room temperature right after production and only show at elevated temperature. That’s why accelerated stability is non-negotiable even for “straightforward” acid formulas.

What’s a typical MOQ for a custom acid exfoliant formula at Mastracare?

For a serum or toner format, our standard MOQ is 500 kg per SKU. If you’re entering multiple acid concentrations (say, a 5% and 10% glycolic line), we can discuss shared base approaches that reduce per-SKU MOQ in some cases. Timeline from signed specification to first production batch runs 10–14 weeks including stability checkpoints.

Should we specify the acid supplier in our PO, or leave it to the manufacturer?

You should specify the material grade, not the supplier, in your PO — and in our intake documentation, we’d suggest you also specify the key parameters from the ACE-RQ6 screen: minimum purity, chirality requirement if relevant, D90 for powders, and the heavy metals limit you need CoA documentation for. Specifying a supplier by name creates a supply chain brittleness that causes problems if that supplier has a lead time disruption. Specifying the material parameters locks in quality while keeping procurement flexible.

---

Have a product concept in mind? Contact our formulation team to request a complimentary brief review.